<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: <z:chebi fb="0" ids="35143">Hemoglobin</z:chebi> A(1c) (A1C) has emerged as a recommended diagnostic tool for identifying <z:mp ids='MP_0002055'>diabetes</z:mp> and subjects at risk for the disease </plain></SENT>
<SENT sid="1" pm="."><plain>This recommendation is based on data in adults showing the relationship between A1C with future development of <z:mp ids='MP_0002055'>diabetes</z:mp> and microvascular complications </plain></SENT>
<SENT sid="2" pm="."><plain>However, studies in the pediatric population are lacking </plain></SENT>
<SENT sid="3" pm="."><plain>RESEARCH DESIGN AND METHODS: We studied a multiethnic cohort of 1,156 <z:mp ids='MP_0001261'>obese</z:mp> children and adolescents without a diagnosis of <z:mp ids='MP_0002055'>diabetes</z:mp> (male, 40%/female, 60%) </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> subjects underwent an oral <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance test (OGTT) and A1C measurement </plain></SENT>
<SENT sid="5" pm="."><plain>These tests were repeated after a follow-up time of âˆ¼2 years in 218 subjects </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: At baseline, subjects were stratified according to A1C categories: 77% with <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance (A1C &lt;5.7%), 21% at risk for <z:mp ids='MP_0002055'>diabetes</z:mp> (A1C 5.7-6.4%), and 1% with <z:mp ids='MP_0002055'>diabetes</z:mp> (A1C &gt;6.5%) </plain></SENT>
<SENT sid="7" pm="."><plain>In the at risk for <z:mp ids='MP_0002055'>diabetes</z:mp> category, 47% were classified with <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">prediabetes</z:e> or <z:mp ids='MP_0002055'>diabetes</z:mp>, and in the <z:mp ids='MP_0002055'>diabetes</z:mp> category, 62% were classified with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> by the OGTT </plain></SENT>
<SENT sid="8" pm="."><plain>The area under the curve receiver operating characteristic for A1C was 0.81 (95% CI 0.70-0.92) </plain></SENT>
<SENT sid="9" pm="."><plain>The threshold for identifying type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> was 5.8%, with 78% specificity and 68% sensitivity </plain></SENT>
<SENT sid="10" pm="."><plain>In the subgroup with repeated measures, a multivariate analysis showed that the strongest predictors of 2-h <z:chebi fb="105" ids="17234">glucose</z:chebi> at follow-up were baseline A1C and 2-h <z:chebi fb="105" ids="17234">glucose</z:chebi>, independently of age, ethnicity, sex, fasting <z:chebi fb="105" ids="17234">glucose</z:chebi>, and follow-up time </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: The American <z:mp ids='MP_0002055'>Diabetes</z:mp> Association suggested that an A1C of 6.5% underestimates the prevalence of <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">prediabetes</z:e> and <z:mp ids='MP_0002055'>diabetes</z:mp> in <z:mp ids='MP_0001261'>obese</z:mp> children and adolescents </plain></SENT>
<SENT sid="12" pm="."><plain>Given the low sensitivity and specificity, the use of A1C by itself represents a poor diagnostic tool for <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">prediabetes</z:e> and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> in <z:mp ids='MP_0001261'>obese</z:mp> children and adolescents </plain></SENT>
</text></document>